Natural history of Tay-Sachs disease in sheep

Tay-Sachs disease (TSD) is a fatal neurodegenerative disease caused by a deficiency of the enzyme β-N-acetylhexosaminidase A (HexA). TSD naturally occurs in Jacob sheep is the only experimental model of TSD. TSD in sheep recapitulates neurologic features similar to juvenile onset and late onset TSD...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular genetics and metabolism 2021-09, Vol.134 (1-2), p.164-174
Hauptverfasser: Story, Brett, Taghian, Toloo, Gallagher, Jillian, Koehler, Jey, Taylor, Amanda, Randle, Ashley, Nielsen, Kayly, Gross, Amanda, Maguire, Annie, Carl, Sara, Johnson, Siauna, Fernau, Deborah, Diffie, Elise, Cuddon, Paul, Corado, Carly, Chandra, Sundeep, Sena-Esteves, Miguel, Kolodny, Edwin, Jiang, Xuntian, Martin, Douglas, Gray-Edwards, Heather
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 174
container_issue 1-2
container_start_page 164
container_title Molecular genetics and metabolism
container_volume 134
creator Story, Brett
Taghian, Toloo
Gallagher, Jillian
Koehler, Jey
Taylor, Amanda
Randle, Ashley
Nielsen, Kayly
Gross, Amanda
Maguire, Annie
Carl, Sara
Johnson, Siauna
Fernau, Deborah
Diffie, Elise
Cuddon, Paul
Corado, Carly
Chandra, Sundeep
Sena-Esteves, Miguel
Kolodny, Edwin
Jiang, Xuntian
Martin, Douglas
Gray-Edwards, Heather
description Tay-Sachs disease (TSD) is a fatal neurodegenerative disease caused by a deficiency of the enzyme β-N-acetylhexosaminidase A (HexA). TSD naturally occurs in Jacob sheep is the only experimental model of TSD. TSD in sheep recapitulates neurologic features similar to juvenile onset and late onset TSD patients. Due to the paucity of human literature on pathology of TSD, a better natural history in the sheep TSD brain, which is on the same order of magnitude as a child's, is necessary for evaluating therapy and characterizing the pathological events that occur. To provide clinicians and researchers with a clearer understanding of longitudinal pathology in patients, we compare spectrum of clinical signs and brain pathology in mildly symptomatic (3-months), moderately symptomatic (6-months), or severely affected TSD sheep (humane endpoint at ~9-months of age). Increased GM2 ganglioside in the CSF of TSD sheep and a TSD specific biomarker on MRS (taurine) correlate with disease severity. Microglial activation and reactive astrocytes were observed globally on histopathology in TSD sheep with a widespread reduction in oligodendrocyte density. Myelination is reduced primarily in the forebrain illustrated by loss of white matter on MRI. GM2 and GM3 ganglioside were increased and distributed differently in various tissues. The study of TSD in the sheep model provides a natural history to shed light on the pathophysiology of TSD, which is of utmost importance due to novel therapeutics being assessed in human patients.
doi_str_mv 10.1016/j.ymgme.2021.08.009
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8811770</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1096719221007733</els_id><sourcerecordid>2566263448</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-385b016d24c2773db8dba3199d6b9443168bd696d08a441d37b8d99939daea443</originalsourceid><addsrcrecordid>eNp9kE1PAyEURYnRWK3-AhMzSzczwsAwsNDENH4ljS6sa8LAa0vTmakwbdJ_L7Uf0Y0rCJx3381B6IrgjGDCb2fZup7UkOU4JxkWGcbyCJ0RLHla5pgf7-9E5j10HsIMY0IKyU5RjzJWcELZGUrfdLf0ep5MXehav07acTLS6_RDm2lIrAugAySuScIUYHGBTsZ6HuByd_bR59PjaPCSDt-fXwcPw9SwQnYpFUUVG9qcmbwsqa2ErTQlUlpeScYo4aKyXHKLhWaMWFpGQkpJpdUQX2gf3W9zF8uqBmug6WJHtfCu1n6tWu3U35_GTdWkXSkhCClLHANudgG-_VpC6FTtgoH5XDfQLoPKC85zHjWIiNItanwbgofxYQ3BaiNazdSPaLURrbBQUXScuv7d8DCzNxuBuy0A0dPKgVfBOGgMWOfBdMq27t8F35Hkj2s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2566263448</pqid></control><display><type>article</type><title>Natural history of Tay-Sachs disease in sheep</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Collection</source><creator>Story, Brett ; Taghian, Toloo ; Gallagher, Jillian ; Koehler, Jey ; Taylor, Amanda ; Randle, Ashley ; Nielsen, Kayly ; Gross, Amanda ; Maguire, Annie ; Carl, Sara ; Johnson, Siauna ; Fernau, Deborah ; Diffie, Elise ; Cuddon, Paul ; Corado, Carly ; Chandra, Sundeep ; Sena-Esteves, Miguel ; Kolodny, Edwin ; Jiang, Xuntian ; Martin, Douglas ; Gray-Edwards, Heather</creator><creatorcontrib>Story, Brett ; Taghian, Toloo ; Gallagher, Jillian ; Koehler, Jey ; Taylor, Amanda ; Randle, Ashley ; Nielsen, Kayly ; Gross, Amanda ; Maguire, Annie ; Carl, Sara ; Johnson, Siauna ; Fernau, Deborah ; Diffie, Elise ; Cuddon, Paul ; Corado, Carly ; Chandra, Sundeep ; Sena-Esteves, Miguel ; Kolodny, Edwin ; Jiang, Xuntian ; Martin, Douglas ; Gray-Edwards, Heather</creatorcontrib><description>Tay-Sachs disease (TSD) is a fatal neurodegenerative disease caused by a deficiency of the enzyme β-N-acetylhexosaminidase A (HexA). TSD naturally occurs in Jacob sheep is the only experimental model of TSD. TSD in sheep recapitulates neurologic features similar to juvenile onset and late onset TSD patients. Due to the paucity of human literature on pathology of TSD, a better natural history in the sheep TSD brain, which is on the same order of magnitude as a child's, is necessary for evaluating therapy and characterizing the pathological events that occur. To provide clinicians and researchers with a clearer understanding of longitudinal pathology in patients, we compare spectrum of clinical signs and brain pathology in mildly symptomatic (3-months), moderately symptomatic (6-months), or severely affected TSD sheep (humane endpoint at ~9-months of age). Increased GM2 ganglioside in the CSF of TSD sheep and a TSD specific biomarker on MRS (taurine) correlate with disease severity. Microglial activation and reactive astrocytes were observed globally on histopathology in TSD sheep with a widespread reduction in oligodendrocyte density. Myelination is reduced primarily in the forebrain illustrated by loss of white matter on MRI. GM2 and GM3 ganglioside were increased and distributed differently in various tissues. The study of TSD in the sheep model provides a natural history to shed light on the pathophysiology of TSD, which is of utmost importance due to novel therapeutics being assessed in human patients.</description><identifier>ISSN: 1096-7192</identifier><identifier>EISSN: 1096-7206</identifier><identifier>DOI: 10.1016/j.ymgme.2021.08.009</identifier><identifier>PMID: 34456134</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Brain - diagnostic imaging ; Brain - physiopathology ; Disease Models, Animal ; Large animal model ; Magnetic Resonance Imaging ; Neurodegeneration ; Sheep ; Tay-Sachs ; Tay-Sachs Disease - genetics ; Tay-Sachs Disease - physiopathology ; Tay-Sachs Disease - veterinary ; Translational ; Veterinary</subject><ispartof>Molecular genetics and metabolism, 2021-09, Vol.134 (1-2), p.164-174</ispartof><rights>2021 Elsevier Inc.</rights><rights>Copyright © 2021 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-385b016d24c2773db8dba3199d6b9443168bd696d08a441d37b8d99939daea443</citedby><cites>FETCH-LOGICAL-c459t-385b016d24c2773db8dba3199d6b9443168bd696d08a441d37b8d99939daea443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1096719221007733$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34456134$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Story, Brett</creatorcontrib><creatorcontrib>Taghian, Toloo</creatorcontrib><creatorcontrib>Gallagher, Jillian</creatorcontrib><creatorcontrib>Koehler, Jey</creatorcontrib><creatorcontrib>Taylor, Amanda</creatorcontrib><creatorcontrib>Randle, Ashley</creatorcontrib><creatorcontrib>Nielsen, Kayly</creatorcontrib><creatorcontrib>Gross, Amanda</creatorcontrib><creatorcontrib>Maguire, Annie</creatorcontrib><creatorcontrib>Carl, Sara</creatorcontrib><creatorcontrib>Johnson, Siauna</creatorcontrib><creatorcontrib>Fernau, Deborah</creatorcontrib><creatorcontrib>Diffie, Elise</creatorcontrib><creatorcontrib>Cuddon, Paul</creatorcontrib><creatorcontrib>Corado, Carly</creatorcontrib><creatorcontrib>Chandra, Sundeep</creatorcontrib><creatorcontrib>Sena-Esteves, Miguel</creatorcontrib><creatorcontrib>Kolodny, Edwin</creatorcontrib><creatorcontrib>Jiang, Xuntian</creatorcontrib><creatorcontrib>Martin, Douglas</creatorcontrib><creatorcontrib>Gray-Edwards, Heather</creatorcontrib><title>Natural history of Tay-Sachs disease in sheep</title><title>Molecular genetics and metabolism</title><addtitle>Mol Genet Metab</addtitle><description>Tay-Sachs disease (TSD) is a fatal neurodegenerative disease caused by a deficiency of the enzyme β-N-acetylhexosaminidase A (HexA). TSD naturally occurs in Jacob sheep is the only experimental model of TSD. TSD in sheep recapitulates neurologic features similar to juvenile onset and late onset TSD patients. Due to the paucity of human literature on pathology of TSD, a better natural history in the sheep TSD brain, which is on the same order of magnitude as a child's, is necessary for evaluating therapy and characterizing the pathological events that occur. To provide clinicians and researchers with a clearer understanding of longitudinal pathology in patients, we compare spectrum of clinical signs and brain pathology in mildly symptomatic (3-months), moderately symptomatic (6-months), or severely affected TSD sheep (humane endpoint at ~9-months of age). Increased GM2 ganglioside in the CSF of TSD sheep and a TSD specific biomarker on MRS (taurine) correlate with disease severity. Microglial activation and reactive astrocytes were observed globally on histopathology in TSD sheep with a widespread reduction in oligodendrocyte density. Myelination is reduced primarily in the forebrain illustrated by loss of white matter on MRI. GM2 and GM3 ganglioside were increased and distributed differently in various tissues. The study of TSD in the sheep model provides a natural history to shed light on the pathophysiology of TSD, which is of utmost importance due to novel therapeutics being assessed in human patients.</description><subject>Animals</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - physiopathology</subject><subject>Disease Models, Animal</subject><subject>Large animal model</subject><subject>Magnetic Resonance Imaging</subject><subject>Neurodegeneration</subject><subject>Sheep</subject><subject>Tay-Sachs</subject><subject>Tay-Sachs Disease - genetics</subject><subject>Tay-Sachs Disease - physiopathology</subject><subject>Tay-Sachs Disease - veterinary</subject><subject>Translational</subject><subject>Veterinary</subject><issn>1096-7192</issn><issn>1096-7206</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1PAyEURYnRWK3-AhMzSzczwsAwsNDENH4ljS6sa8LAa0vTmakwbdJ_L7Uf0Y0rCJx3381B6IrgjGDCb2fZup7UkOU4JxkWGcbyCJ0RLHla5pgf7-9E5j10HsIMY0IKyU5RjzJWcELZGUrfdLf0ep5MXehav07acTLS6_RDm2lIrAugAySuScIUYHGBTsZ6HuByd_bR59PjaPCSDt-fXwcPw9SwQnYpFUUVG9qcmbwsqa2ErTQlUlpeScYo4aKyXHKLhWaMWFpGQkpJpdUQX2gf3W9zF8uqBmug6WJHtfCu1n6tWu3U35_GTdWkXSkhCClLHANudgG-_VpC6FTtgoH5XDfQLoPKC85zHjWIiNItanwbgofxYQ3BaiNazdSPaLURrbBQUXScuv7d8DCzNxuBuy0A0dPKgVfBOGgMWOfBdMq27t8F35Hkj2s</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Story, Brett</creator><creator>Taghian, Toloo</creator><creator>Gallagher, Jillian</creator><creator>Koehler, Jey</creator><creator>Taylor, Amanda</creator><creator>Randle, Ashley</creator><creator>Nielsen, Kayly</creator><creator>Gross, Amanda</creator><creator>Maguire, Annie</creator><creator>Carl, Sara</creator><creator>Johnson, Siauna</creator><creator>Fernau, Deborah</creator><creator>Diffie, Elise</creator><creator>Cuddon, Paul</creator><creator>Corado, Carly</creator><creator>Chandra, Sundeep</creator><creator>Sena-Esteves, Miguel</creator><creator>Kolodny, Edwin</creator><creator>Jiang, Xuntian</creator><creator>Martin, Douglas</creator><creator>Gray-Edwards, Heather</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210901</creationdate><title>Natural history of Tay-Sachs disease in sheep</title><author>Story, Brett ; Taghian, Toloo ; Gallagher, Jillian ; Koehler, Jey ; Taylor, Amanda ; Randle, Ashley ; Nielsen, Kayly ; Gross, Amanda ; Maguire, Annie ; Carl, Sara ; Johnson, Siauna ; Fernau, Deborah ; Diffie, Elise ; Cuddon, Paul ; Corado, Carly ; Chandra, Sundeep ; Sena-Esteves, Miguel ; Kolodny, Edwin ; Jiang, Xuntian ; Martin, Douglas ; Gray-Edwards, Heather</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-385b016d24c2773db8dba3199d6b9443168bd696d08a441d37b8d99939daea443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - physiopathology</topic><topic>Disease Models, Animal</topic><topic>Large animal model</topic><topic>Magnetic Resonance Imaging</topic><topic>Neurodegeneration</topic><topic>Sheep</topic><topic>Tay-Sachs</topic><topic>Tay-Sachs Disease - genetics</topic><topic>Tay-Sachs Disease - physiopathology</topic><topic>Tay-Sachs Disease - veterinary</topic><topic>Translational</topic><topic>Veterinary</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Story, Brett</creatorcontrib><creatorcontrib>Taghian, Toloo</creatorcontrib><creatorcontrib>Gallagher, Jillian</creatorcontrib><creatorcontrib>Koehler, Jey</creatorcontrib><creatorcontrib>Taylor, Amanda</creatorcontrib><creatorcontrib>Randle, Ashley</creatorcontrib><creatorcontrib>Nielsen, Kayly</creatorcontrib><creatorcontrib>Gross, Amanda</creatorcontrib><creatorcontrib>Maguire, Annie</creatorcontrib><creatorcontrib>Carl, Sara</creatorcontrib><creatorcontrib>Johnson, Siauna</creatorcontrib><creatorcontrib>Fernau, Deborah</creatorcontrib><creatorcontrib>Diffie, Elise</creatorcontrib><creatorcontrib>Cuddon, Paul</creatorcontrib><creatorcontrib>Corado, Carly</creatorcontrib><creatorcontrib>Chandra, Sundeep</creatorcontrib><creatorcontrib>Sena-Esteves, Miguel</creatorcontrib><creatorcontrib>Kolodny, Edwin</creatorcontrib><creatorcontrib>Jiang, Xuntian</creatorcontrib><creatorcontrib>Martin, Douglas</creatorcontrib><creatorcontrib>Gray-Edwards, Heather</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular genetics and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Story, Brett</au><au>Taghian, Toloo</au><au>Gallagher, Jillian</au><au>Koehler, Jey</au><au>Taylor, Amanda</au><au>Randle, Ashley</au><au>Nielsen, Kayly</au><au>Gross, Amanda</au><au>Maguire, Annie</au><au>Carl, Sara</au><au>Johnson, Siauna</au><au>Fernau, Deborah</au><au>Diffie, Elise</au><au>Cuddon, Paul</au><au>Corado, Carly</au><au>Chandra, Sundeep</au><au>Sena-Esteves, Miguel</au><au>Kolodny, Edwin</au><au>Jiang, Xuntian</au><au>Martin, Douglas</au><au>Gray-Edwards, Heather</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Natural history of Tay-Sachs disease in sheep</atitle><jtitle>Molecular genetics and metabolism</jtitle><addtitle>Mol Genet Metab</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>134</volume><issue>1-2</issue><spage>164</spage><epage>174</epage><pages>164-174</pages><issn>1096-7192</issn><eissn>1096-7206</eissn><abstract>Tay-Sachs disease (TSD) is a fatal neurodegenerative disease caused by a deficiency of the enzyme β-N-acetylhexosaminidase A (HexA). TSD naturally occurs in Jacob sheep is the only experimental model of TSD. TSD in sheep recapitulates neurologic features similar to juvenile onset and late onset TSD patients. Due to the paucity of human literature on pathology of TSD, a better natural history in the sheep TSD brain, which is on the same order of magnitude as a child's, is necessary for evaluating therapy and characterizing the pathological events that occur. To provide clinicians and researchers with a clearer understanding of longitudinal pathology in patients, we compare spectrum of clinical signs and brain pathology in mildly symptomatic (3-months), moderately symptomatic (6-months), or severely affected TSD sheep (humane endpoint at ~9-months of age). Increased GM2 ganglioside in the CSF of TSD sheep and a TSD specific biomarker on MRS (taurine) correlate with disease severity. Microglial activation and reactive astrocytes were observed globally on histopathology in TSD sheep with a widespread reduction in oligodendrocyte density. Myelination is reduced primarily in the forebrain illustrated by loss of white matter on MRI. GM2 and GM3 ganglioside were increased and distributed differently in various tissues. The study of TSD in the sheep model provides a natural history to shed light on the pathophysiology of TSD, which is of utmost importance due to novel therapeutics being assessed in human patients.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34456134</pmid><doi>10.1016/j.ymgme.2021.08.009</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1096-7192
ispartof Molecular genetics and metabolism, 2021-09, Vol.134 (1-2), p.164-174
issn 1096-7192
1096-7206
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8811770
source MEDLINE; Elsevier ScienceDirect Journals Collection
subjects Animals
Brain - diagnostic imaging
Brain - physiopathology
Disease Models, Animal
Large animal model
Magnetic Resonance Imaging
Neurodegeneration
Sheep
Tay-Sachs
Tay-Sachs Disease - genetics
Tay-Sachs Disease - physiopathology
Tay-Sachs Disease - veterinary
Translational
Veterinary
title Natural history of Tay-Sachs disease in sheep
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T15%3A36%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Natural%20history%20of%20Tay-Sachs%20disease%20in%20sheep&rft.jtitle=Molecular%20genetics%20and%20metabolism&rft.au=Story,%20Brett&rft.date=2021-09-01&rft.volume=134&rft.issue=1-2&rft.spage=164&rft.epage=174&rft.pages=164-174&rft.issn=1096-7192&rft.eissn=1096-7206&rft_id=info:doi/10.1016/j.ymgme.2021.08.009&rft_dat=%3Cproquest_pubme%3E2566263448%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2566263448&rft_id=info:pmid/34456134&rft_els_id=S1096719221007733&rfr_iscdi=true